Distraction osteogenesis is a surgical technique used in oral, orthopedic, and maxillofacial surgery for treatment of various pathological conditions and skeletal deformities such as leg length discrepancy, bone deformity or bone defects also termed as callotasis, callus distraction, and osteodistraction. Distraction osteogenesis is also a treatment option for adults and children with unilateral or bilateral mandibular hypoplasia. It is also used as treatment option for widening an excessively narrow mandible. Moreover, distraction osteogenesis is also an alternative treatment for management of airway obstruction, continuity, reconstruction after a resection, defects of the mandible, and alveolar crest augmentation.
Furthermore, distraction osteogenesis is indicated in the following cases such as severe retrognathia associated with syndrome, mostly seen in infants and children; Nonsyndromic mandibular hypoplasia, patients with unilateral hypoplasia of the mandible, patients with severe Obstructive sleep apnea (OSA).
Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1172
Rise in cases of bone defects is expected to fuel growth of the distraction osteogenesis devices market in the near future
Distraction osteogenesis devices has aided in field of orthopedics, maxillofacial, and oral surgery. Application of distraction osteogenesis offers novel solutions for surgical-orthodontic skeleton and asymmetries to treat the rising number of bone defects cases. According to Centre for Disease Control and Prevention, in the U.S. each year about 2,650 babies are born with cleft palate. Adoption of novel technologies such as better implant material and minimal invasive surgery is also a factor in turn favoring growth of distraction osteogenesis device market.
Furthermore, according to data published in Critical Reviews in Biomedical Engineering Journal in 2012, annually in the U.S., over half a million patients receive bone defect repairs, costing around US$ 2.5 billion and this is expected to increase by 2020, which in turn favors growth of the distraction osteogenesis devices market.
New product developments are also expected to favor the growth of distraction osteogenesis devices market. For instance, in October 2017, DePuy Synthes is launched the MAXFRAME Multi-Axial Correction System, an external circular fixation device used to gradually correct bone or soft tissue deformities in the arm, leg, foot or ankle. Furthermore, in April 2017, NuVasive, Inc., a medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced the launch the new RELINE. RELINE Trauma enhances the surgeon’s ability to dial-in fracture correction through a dual rack system achieving independent lordosis restoration and parallel compression/distraction for ligamentotaxis.
North America is expected to be dominant in the global distraction osteogenesis devices market over the forecast period
North America market accounted for the largest share in the global distraction osteogenesis devices market, followed by Europe market in 2016. This is attributed to robust healthcare infrastructure and increasing rate of sports-related injuries in the region. For instance, According to Center for Disease Control and Prevention, in the U.S. in 2016, around 2 million high school athletes are reported with injuries, with head injuries accounting for 14% each year.
The distraction osteogenesis devices market is expected to exhibit high growth rate in Asia Pacific region over the forecast period, due to increasing prevalence of road accidents. As according to A Report on Road Accidents in India 2016, published by Transport Research wing under Ministry of Road Transport & Highways, Government of India, the country recorded at least 4,80,652 accidents in 2016, leading to 1,50,785 deaths.
Request for complete TOC of this report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1172
Key players are expected to account for a large share in the global distraction osteogenesis devices market over the forecast period
Key players are focusing on research and development for new innovation in osteogenesis devices. In October 2017, DePuy Synthes introduced a device for gradual correction of bone or soft tissue deformities. The feature of the device is its accompanying 3D planning software designed to cut treatment times and lower costs, which is expected to aid in the global distraction osteogenesis device market growth.
Key players operating in the global distraction osteogenesis devices market includes Johnson & Johnson, Zimmer Biomet Holdings, Inc., Stryker, KLS Martin Group, Jeil Medical Corporation, OsteoMed, and Ningbo Cibei Medical Treatment Appliance Co., Ltd.